Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000006

PRESIDENT AND COO sold 22,500 shares at an average $450.24 ($10,130,439)

  • PRESIDENT AND COO acquired 22,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-06 Exercise or conversion : show line 1 in the form 10b5-1 +14,625 $135.42 $1,980,518 14,625 I
2025-10-06 Sale : show line 2 in the form 10b5-1 −400 $449.82 $179,928 14,225 I
2025-10-06 Sale : show line 3 in the form 10b5-1 −800 $450.97 $360,777 13,425 I
2025-10-06 Sale : show line 4 in the form 10b5-1 −11,975 $452.03 $5,413,011 1,450 I
2025-10-06 Sale : show line 5 in the form 10b5-1 −1,250 $453.16 $566,449 200 I
2025-10-06 Sale : show line 6 in the form 10b5-1 −200 $253.98 $50,795 0 I
2025-10-06 Exercise or conversion : show line 7 in the form 10b5-1 +7,875 $146.03 $1,149,986 7,875 I
2025-10-06 Sale : show line 8 in the form 10b5-1 −300 $450.06 $135,017 7,575 I
Open-market sales · 22,500 sh · avg $450.24 · $10,130,439

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-10-06 Exercise or conversion : show line 13 in the form 10b5-1 Stock Options −14,625 $135.42 2027-03-15 14,325 99,750 I
2025-10-06 Exercise or conversion : show line 14 in the form 10b5-1 Stock Options −7,875 $146.03 2027-03-15 7,875 17,500 I
Loading xslF345X05/primarydocument.xml…